Newly recruited CD11b+, GR-1+, Ly6Chigh myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus

Derek R. Clements, Andra M. Sterea, Youra Kim, Erin Helson, Cheryl A. Dean, Anna Nunokawa, Krysta Mila Coyle, Tanveer Sharif, Paola Marcato, Shashi A. Gujar, Patrick W.K. Lee

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)
Original languageEnglish
Pages (from-to)4397-4412
Number of pages16
JournalJournal of Immunology
Volume194
Issue number9
DOIs
Publication statusPublished - May 1 2015
Externally publishedYes

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Newly recruited CD11b+, GR-1+, Ly6Chigh myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus'. Together they form a unique fingerprint.

Cite this